Trial
NCT04123418
A Study of WVT078 in Patients With Multiple Myeloma (MM)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Multiple Myeloma (MM)
Intervention
WVT078
Why stopped
The decision was made for business reasons and was not based on any safety or tolerability concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-24